Can Epclusa be purchased in regular pharmacies?

Epclusa (sofosbuvir/velpatasvir) is an oral antiviral drug used to treat multiple genotypes of hepatitis C. It has been approved for marketing in my country and has been included in the medical insurance catalog. This means that patients can purchase the drug in regular hospital pharmacies or qualified pharmacies, and the patient's burden is greatly reduced after using medical insurance. For patients diagnosed with hepatitis C, it is recommended to obtain medicines through formal channels under the guidance of a doctor, and develop an appropriate treatment plan according to their personal condition.

At present, the price of Jisandai in China is about more than 3,000 yuan per box, but since it has been included in medical insurance, the out-of-pocket amount of some patients will be further reduced. The specific price and reimbursement ratio vary depending on the region, medical insurance policy and hospital level. It is recommended that patients go to the local top tertiary hospital or medical insurance designated pharmacy for detailed consultation. At the same time, medications should be purchased after being prescribed by a professional doctor to ensure they are safe and effective, and avoid purchasing online or obtaining them through informal channels.

In addition to domestic original drugs, there are also third-generation generic drugs from countries such as India and Bangladesh on the market. These drugs are similar to the original drugs in terms of ingredients and efficacy, but are more affordable, generally around a few hundred yuan. Although generic drugs can be used as an alternative for price-sensitive patients, their acquisition channels mostly rely on overseas drug purchasing platforms or third-party purchasing agents, which poses certain legal and quality risks. Before considering using overseas generic drugs, patients should carefully evaluate and seek professional medical advice whenever possible.

In general, as a broad-spectrum drug for the treatment of hepatitis C, Jisandai already has formal drug purchase channels in China, and its price has dropped significantly compared with the initial stage of its launch. For most patients, it is safer and more secure to choose to purchase through the hospital or the medical insurance system. If you consider overseas generic drugs, you need to pay special attention to the legality and reliability of the source of the drugs to avoid affecting the therapeutic effect or causing unnecessary health risks due to the pursuit of low prices.

Reference: https://www.epclusa.com/